METLIFE INCMET
METLIFE INC Financial Overview 2020–2024
MetLife has engineered a massive capital return program that retired over 22% of its outstanding stock. This relentless buyback engine underscores a broader investment thesis: by aggressively shedding legacy liabilities through multi-billion-dollar reinsurance deals and pivoting toward asset management, the insurer is transforming into a more predictable, capital-efficient enterprise.
While extreme interest rate volatility and derivative swings frequently masked the company's underlying performance, its core financial foundation remained intact. Highlighting this long-term arc, outstanding shares dropped steadily from 0.89 billion in FY2020 to 0.69 billion by the close of FY2024, while earnings per share rebounded from a derivative-driven trough of $1.81 in FY2023 to $5.94 in FY2024. To insulate its balance sheet from future macro shocks and fund an upgraded adjusted return on equity target of 15% to 17%, the company offloaded massive blocks of statutory reserves to third-party reinsurers like Talcott Resolution and Chariot Re.
These aggressive risk-transfer actions freed up vast liquidity, allowing the firm to return approximately $21.0 billion to shareholders between FY2020 and FY2024. With total assets climbing to $719.7 billion by Q3 2025 and an estimated $25.0 billion in free cash flow projected over the next five years, MetLife has built a highly defensive balance sheet. The targeted acquisition of PineBridge Investments further accelerates this strategic rotation into capital-light, fee-based revenue, ensuring the financial engine is primed for sustained growth.
Recent Developments (Q2 and Q3 2025)
MetLife’s recent performance highlighted a stark divergence between headline profitability and operational stability. In Q3 2025, net income plunged to $818 million, or $1.22 per share, down from $1.3 billion in Q3 2024. This drop stemmed from a $1.7 billion unfavorable swing in net derivative losses tied to currency and interest rate fluctuations. However, adjusted earnings climbed to $1.6 billion from $1.4 billion year-over-year, supported by volume growth across Asia and Latin America. Operationally, the firm restructured its reporting segments, establishing MetLife Investment Management as a standalone unit to accelerate its capital-light strategy. Bulls highlight the firm's underlying adjusted earnings resilience despite market volatility. Bears warn that unpredictable macro conditions continue to trigger massive derivative losses. Trading at 12.8x earnings as of the Q3 2025 reporting date, the equity appears cheaply valued given its core operational strength.
What to watch: whether Q4 2025 variable investment income meets the lowered $385 million to $435 million projection; initial financial metrics from the newly standalone MetLife Investment Management segment.
Rev
$70.99B
FY2024
NI
$4.43B
FY2024
EPS$MET
$5.98
FY2024
OCF
$14.60B
FY2024
Year-over-year comparison from 10-K annual reports
Data from SEC Company Facts
Recent SEC Filings
METLIFE INC 8-K Report, Corporate Update (Feb 17, 2026)
MetLife, Inc. (MET) has filed an 8-K report on February 17, 2026, primarily announcing the declaration of various preferred stock dividends. Investors should note the specific dividend amounts and frequencies for Series D, Series E, Series F, and Series A preferred stock. The declaration of these dividends indicates the company's ongoing commitment to returning capital to its shareholders, a positive sign for preferred stockholders.
METLIFE INC 8-K Report, Financial Results (Feb 4, 2026)
MetLife, Inc. has filed an 8-K report on February 4, 2026, detailing its financial results for the quarter and full year ended December 31, 2025, and providing an outlook for 2026. The company's outlook acknowledges continued economic uncertainty regarding inflation and unemployment, while expecting a relatively stable U.S. dollar and a moderate rise in long-term interest rates with a steepening yield curve in 2026. MetLife highlights its robust capital position, maintaining $3.6 billion in holding company cash, within its target range, and reiterates its commitment to returning capital to shareholders, having returned approximately $4.4 billion in 2025 and remaining on track to generate $25.0 billion in free cash flow over the 2025-2029 period.
METLIFE INC 8-K Report, Regulation FD Disclosure (Jan 9, 2026)
MetLife, Inc. (MET) has announced a significant organizational restructuring effective in the fourth quarter of 2025, aimed at accelerating growth in its asset management business. The key change involves elevating MetLife Investment Management (MIM) to a standalone reportable segment. Previously, MIM was housed within 'Corporate & Other'. This move is intended to provide greater visibility and focus on the company's institutional asset management capabilities. In conjunction with this, MetLife Holdings will no longer be a reportable segment and its results will primarily be integrated into 'Corporate & Other'. Additionally, certain product lines formerly within MetLife Holdings have been realigned into the Group Benefits and Retirement and Income Solutions (RIS) segments. These segment changes have been applied retrospectively to prior periods for enhanced comparability. The company also adjusted inter-company management fee agreements for MIM to reflect current market rates, a change also applied retrospectively. Importantly, these organizational and accounting adjustments did not impact prior consolidated net income or adjusted earnings.
METLIFE INC 8-K Report, Regulation FD Disclosure (Dec 30, 2025)
MetLife, Inc. (MET) has filed an 8-K report on December 30, 2025, announcing the successful closing of its acquisition of PineBridge Investments, LLC and its affiliates by MetLife Investment Management. This strategic move significantly expands MetLife's investment management capabilities and assets under management. The company also released a pro forma fact sheet detailing the combined total assets under management (AUM) as if the acquisition had occurred on September 30, 2025. This information provides investors with a clear picture of the scale and potential impact of this significant transaction on MetLife's investment arm.
METLIFE INC 8-K Report, Regulation FD Disclosure (Dec 22, 2025)
MetLife, Inc. has filed an 8-K report to provide investors with a preliminary update on its financial performance and outlook for the fiscal year ending December 31, 2025, ahead of its official earnings release. The company anticipates variable investment income for the fourth quarter of 2025 to be between $385 million and $435 million (pre-tax), slightly below its quarterly target of $425 million, but expects its full-year 2025 variable investment income to be around $1.7 billion (pre-tax). In terms of capital management, MetLife is prioritizing organic growth, with an estimated $4 billion deployed in 2025, and an additional $1 billion for M&A, including the pending acquisition of PineBridge Investments. The company also expects to repurchase approximately $2.85 billion of its common stock in 2025, a level it anticipates maintaining in 2026. Investors should note that this information is preliminary and unaudited, and actual results could materially differ.
View all 8-K filings →